Clinical characteristics and response to tyrosine kinase inhibitors of patients with non-small cell

• 作 者: Yan Zhang Zheng Wang Xuezhi Ha
• 机 构: DepartmentofMedicalOncology,DepartmentofPathology,DepartmentofPathology
• 出 处: 中国癌症研究：英文版
• 发表日期: 2017年1期
• 关键词: 酪氨酸激酶抑制剂 表皮生长因子受体 非小细胞肺癌 插入突变 临床特征 反应率 患者 表皮细胞 Non-small cell lung cancer EGFR u
• 基金项目: supported by the funding from Chinese Geriatric Oncology Society （CGOS） （No. H08151）

Objective: To investigate the clinical features of patients with non-small cell lung cancer(NSCLC) harboring uncommon epidermal growth factor receptor(EGFR) mutations, and the treatment outcomes of EGFR tyrosine kinase inhibitors(TKIs) in these patients.M